Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784766 · ClinicalTrials.gov registry record · NA
Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial
A NA study, sponsored by University of Oklahoma.
- Active
- Registry status
- NA
- Development phase
- 494
- Enrollment target
NCT05784766 is a NA study that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 494 participants.
The verdict
NCT05784766, a NA study, is active but no longer recruiting, sponsored by University of Oklahoma.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 494 participants
- Enrollment target
Study Summary
Patients with cancer have a higher incidence of AF but despite the higher incidence of AF in the cancer population, there are no randomized controlled trials (RCTs) for AF screening in this population. RCTs of AF screening in the general population have shown that screening can effectively detect AF earlier, and helps to identify candidates for appropriate anticoagulation that may lead to improvement in clinical outcomes.
Interventions
- DIAGNOSTIC_TEST 30-second ECG using the Kardia Mobile
- OTHER routine care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05784766
The ClinicalTrials.gov registry entry for NCT05784766 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 30-second ECG using the Kardia Mobile is the first listed.
NCT05784766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05784766 about?
NCT05784766 is a clinical study titled "Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial". Patients with cancer have a higher incidence of AF but despite the higher incidence of AF in the cancer population, there are no randomized controlled trials (RCTs) for AF screening in this population. RCTs of AF screening in the general population have shown that screening can effectively detect AF...
What is the current status of trial NCT05784766?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 494 participants. The study started on 2023-11-06. Estimated completion is 2027-01.
What interventions are being tested in trial NCT05784766?
The interventions under investigation include: 30-second ECG using the Kardia Mobile (DIAGNOSTIC_TEST), routine care (OTHER).
Who is sponsoring clinical trial NCT05784766?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.